gefitinib相关论文
研究背景:CMTM,原名CKLFSF,是北京大学免疫学系于2003年首次报道的基因家族。在人类,该家族包括9个基因,即:CKLF和CMTM1-8（原名CKLF......
Chemotherapy with or without gefitinib in patients with advanced non-small-cell lung cancer: a meta-
...
Epidermal growth factor receptor genotype in plasma DNA and outcome of chemotherapy in the Chinese p
...
Fibroblasts weaken the anti-tumor effect of gefitinib on co-cultured non-small cell lung cancer cell
...
目的分析一线应用埃克替尼和吉非替尼治疗晚期表皮生长因子受体(EGFR)阳性肺腺癌患者的疗效。方法回顾性分析120例口服埃克替尼或......
目的观察放疗联合吉非替尼治疗老年人中晚期非小细胞肺癌的近期及远期疗效。方法选取临沂市第三人民医院2012年10月至2015年10月确......
目的观察吉非替尼联合羟基喜树碱心包灌注用于晚期非小细胞肺癌(NSCLC)伴心包积液的临床效果。方法选取胶州市人民医院2016年1月至......
目的探讨吉非替尼联合胸部同步放疗在治疗表皮生长因子受体(EGFR)基因突变敏感型局部晚期非鳞肺癌患者中的临床获益及安全性。方法......
目的探讨顺铂与吉西他滨联合化学治疗对中晚期非小细胞肺癌患者的影响。方法选取2014年3月至2015年3月山东省滨州市中心医院肿瘤科......
1例70岁男性晚期肺癌患者口服吉非替尼250 mg、1次/d。此前患者因瓣膜关闭不全行主动脉瓣置换术及冠状动脉搭桥术，术后长期规范服用......
背景:全世界的统计数据表明,肺癌仍然是导致癌症发生率和癌症死亡率较高的主要原因(占癌症死亡总数的18.4%)和最常被诊断出的癌症......
目的 探讨吉非替尼对2型糖尿病鼠胰岛素敏感性的影响及其相关机制.方法 高糖高脂饲料喂养大鼠1个月后腹腔注射链脲霉素制成2型糖尿......
目的:探讨吉非替尼诱发的严重间质性肺病(interstitial lung disease,ILD)的发病机制、诊断与治疗。方法:对1例吉非替尼导致的ILD......
Chemotherapy with or without gefitinib in patients with advanced non-small-cell lung cancer: a meta-
该文从挂篮荷载计算、施工流程、支座及临时固结施工、挂篮安装及试验、合拢段施工、模板制作安装、钢筋安装、混凝土的浇筑及养生......
目的 观察吉非替尼单药治疗老年人晚期非小细胞肺癌的疗效和不良反应.方法 老年晚期非小细胞肺癌患者30例,采用口服吉非替尼治疗,2......
目的比较表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKIs)与化疗二线治疗晚期非小细胞肺癌的有效性和安全性。方法检索Cochrane Libr......
Improvements in quality of life and disease-related symptoms in patients with advanced non-small cel
Most patients with advanced non-small cell lung cancer (NSCLC) experienced mild to severe disease-related symptoms incl......
Efficacy and safety of gefitinib as monotherapy for Chinese patients with advanced non-small cell lu
Platinum-based chemotherapy can improve the survival and quality of life of patients with locally advanced and metastat......
Gefitinib-induced disseminated intravascular coagulation in a patient with non-small cell lung cance
In February 2005, Gefitinib (Iressa), a small-molecular epidermal growth factor receptor and tyrosine kinase inhibitor,......
Manifestation of leukoencephalopathy in a patient with advanced non-small cell lung cancer following
The present case is a patient with advanced non-small cell lung cancer (NSCLC) who developed leukoencephalopathy followi......
Erlotinib as a salvage treatment for patients with advanced non-small cell lung cancer after failure
Background Several clinical trials showed that erlotinib was effective after the failure of gefitinib in advanced non-sm......
...
Fibroblasts weaken the anti-tumor effect of gefitinib on co-cultured non-small cell lung cancer cell
Background Non-small cell lung cancer (NSCLC) is the most common lung malignancy worldwide.The metastatic potential of N......
为探究吕家坨井田地质构造格局,根据钻孔勘探资料,采用分形理论和趋势面分析方法,研究了井田7......
为了让临床工作者及时掌握有些药物的不良反应,就临床中遇到的1例克咳胶囊致口服吉非替尼肺癌患者过敏性肺炎进行分析,通过对本例......
A 45-year-old man with bronchioloalveolar carcinoma was treated with gefitinib. The most severe side effect was hemorrha......
Objective: To investigate whether laminin 5 (LN5) might be a predictor in lung cancer patient treated with gefitinib and......
Objective:We conducted a prospective phase Ⅱ trial of single-agent salvage chemotherapy with docetaxel in patients with......
EGFR/HER2/HER3 expression in tumour and gefitinib treatment in Chinese patients with advanced non-sm
为探究吕家坨井田地质构造格局,根据钻孔勘探资料,采用分形理论和趋势面分析方法,研究了井田7......
e all more than 40%. QoL and symptom response correlated with disease control. The patients with better QoL had longer s......
Objective: We observe the curative effect, median survival time, time to progression, quality of life and adverse effect......
Objective: The aim of our study was to evaluate the efficacy and safety of gefitinib combined with γ-ray stereotactic r......
Gefitinib combined with γ-ray stereotactic body radiation therapy has better efficacy than gefitinib
为探究吕家坨井田地质构造格局,根据钻孔勘探资料,采用分形理论和趋势面分析方法,研究了井田7......
The influence of autologous cytokine-induced killer cell treatment on the objective efficacy and saf
为探究吕家坨井田地质构造格局,根据钻孔勘探资料,采用分形理论和趋势面分析方法,研究了井田7......
The relationship between tyrosine kinase inhibitor therapy and overall survival in patients with non
为探究吕家坨井田地质构造格局,根据钻孔勘探资料,采用分形理论和趋势面分析方法,研究了井田7......
Toxic epidermal necrolysis related to AP (pemetrexed plus cisplatin) and gefitinib combination thera
为探究吕家坨井田地质构造格局,根据钻孔勘探资料,采用分形理论和趋势面分析方法,研究了井田7......
为探究吕家坨井田地质构造格局,根据钻孔勘探资料,采用分形理论和趋势面分析方法,研究了井田7......
目的 观察表皮生长因子受体酪氨酸激酶抑制剂吉非替尼对人结肠癌细胞的生长抑制作用,探讨这种作用与结肠癌细胞PTEN表达的关系.方......
EGFR/HER2/HER3 expression in tumour and gefitinib treatment in Chinese patients with advanced non-sm
Objective: Biological markers performable in routine practice and able to predict the clinical outcome of advanced non-s......
Objective:We conducted a prospective phase Ⅱ trial of single-agent salvage chemotherapy with docetaxel in patients with......
目的 评价吉非替尼一线治疗并发脑转移的非小细胞肺癌的疗效和不良反应.方法 17例晚期肺癌接受吉非替尼250 mg/d,连服30 d为1个治......
Objective: To investigate whether laminin 5 (LN5) might be a predictor in lung cancer patient treated with gefitinib and......
目的 探讨吉非替尼与多西他赛以不同顺序同步或序贯给药对于不同细胞株的细胞增殖能力及细胞周期和凋亡的影响.方法 用四甲基偶氮......
目的探讨在Gefitinib 作用下前列腺癌DU145细胞表皮生长因子受体(EGFR)、促分裂原活化蛋白激酶(MAPK)、丝氨酸蛋白激酶(AKt)及蛋白......
目的研究吉非替尼对晚期非小细胞肺癌的治疗效果。方法选取某院2011年2月～2012年2月收治的期非小细胞肺癌,不能耐受化疗或化疗失败......
目的 观察吉非替尼对既往化学治疗有效的晚期(Ⅳ期)非小细胞肺癌维持治疗的疗效和安全性.方法 在15例经病理学确诊的非小细胞肺癌......
目的：观察吉非替尼和多西他赛+顺铂方案治疗晚期非小细胞肺癌(NSCLC)的近期疗效、生活质量和不良反应。方法：92例晚期NSCLC患者,试验......
目的 评价吉非替尼维持治疗晚期非小细胞肺癌(NSCLC)的疗效和安全性.方法 173例晚期NSCLC患者化疗后给予吉非替尼治疗,其中62例为......
目的 评价晚期非小细胞肺癌(NSCLC)一线化疗获得部分缓解(PR)或稳定(SD)后予以吉非替尼单药维持治疗的临床疗效.方法 应用前瞻性随......
背景与目的 既往表皮生长因子受体酪氨酸激酶抑制剂(epidermal growth factor receptor tyrosine kinase inhibitor,EGFR-TKI)治疗......
